Literature DB >> 33484110

Analysis of changes in circular RNA expression and construction of ceRNA networks in human dilated cardiomyopathy.

Zhenhao Lin1,2, Yongchao Zhao1,2, Fangjie Dai1,2, Enyong Su1,2, Fuhai Li1,2, Yan Yan1,2.   

Abstract

Dilated cardiomyopathy (DCM) is a severe life-threatening disease worldwide, and the underlying mechanisms remain unclear. Circular RNAs (circRNAs) have been reported to play important roles in various cardiovascular diseases and can function as competitive endogenous RNAs (ceRNAs). However, their role in human DCM has not been fully elucidated. In the present study, heart samples from DCM patients and healthy controls were used to identify circRNAs by RNA sequencing. Real-time quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was conducted to validate differentially expressed circRNAs and mRNAs. A total of 9585 circRNAs and 22050 mRNAs were detected in the two groups. Overall, 213 circRNAs and 617 mRNAs were significantly up-regulated in the DCM group compared with the control group. Similarly, 85 circRNAs and 1125 mRNAs were significantly down-regulated. According to the ceRNA theory, circRNAs can indirectly interact with mRNAs by directly binding to microRNAs (miRNAs), and circRNAs and mRNAs should be concurrently either up-regulated or down-regulated. Based on this theory, we constructed two circRNA-miRNA-mRNA networks by using the RNA sequencing data and prediction by proprietary software. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed to probe the potential functions of differentially expressed circRNAs. In conclusion, this study revealed that the expression of cardiac circRNAs was altered in human DCM and explored the potential functions of circRNAs by constructing ceRNA networks. These findings provide a foundation for future studies of circRNAs in DCM.
© 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

Entities:  

Keywords:  RNA sequencing; circular RNA; competitive endogenous RNA; dilated cardiomyopathy; mRNA

Year:  2021        PMID: 33484110      PMCID: PMC7933965          DOI: 10.1111/jcmm.16251

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  36 in total

1.  A landscape of circular RNA expression in the human heart.

Authors:  Wilson L W Tan; Benson T S Lim; Chukwuemeka G O Anene-Nzelu; Matthew Ackers-Johnson; Albert Dashi; Kelvin See; Zenia Tiang; Dominic Paul Lee; Wee Woon Chua; Tuan D A Luu; Peter Y Q Li; Arthur Mark Richards; Roger S Y Foo
Journal:  Cardiovasc Res       Date:  2017-03-01       Impact factor: 10.787

Review 2.  Dilated cardiomyopathy.

Authors:  Robert G Weintraub; Christopher Semsarian; Peter Macdonald
Journal:  Lancet       Date:  2017-02-10       Impact factor: 79.321

3.  Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation.

Authors:  Cameron Donaldson; Sarah Eder; Corey Baker; Mark J Aronovitz; Alexandra Dabreo Weiss; Monica Hall-Porter; Feng Wang; Adam Ackerman; Richard H Karas; Jeffery D Molkentin; Richard D Patten
Journal:  Circ Res       Date:  2008-12-12       Impact factor: 17.367

4.  Circular RNAs are a large class of animal RNAs with regulatory potency.

Authors:  Sebastian Memczak; Marvin Jens; Antigoni Elefsinioti; Francesca Torti; Janna Krueger; Agnieszka Rybak; Luisa Maier; Sebastian D Mackowiak; Lea H Gregersen; Mathias Munschauer; Alexander Loewer; Ulrike Ziebold; Markus Landthaler; Christine Kocks; Ferdinand le Noble; Nikolaus Rajewsky
Journal:  Nature       Date:  2013-02-27       Impact factor: 49.962

5.  MicroRNA-mediated epigenetic silencing of sirtuin1 contributes to impaired angiogenic responses.

Authors:  Ingo Volkmann; Regalla Kumarswamy; Nils Pfaff; Jan Fiedler; Seema Dangwal; Angelika Holzmann; Sandor Batkai; Robert Geffers; Achim Lother; Lutz Hein; Thomas Thum
Journal:  Circ Res       Date:  2013-08-19       Impact factor: 17.367

Review 6.  Phosphoinositides: tiny lipids with giant impact on cell regulation.

Authors:  Tamas Balla
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

Review 7.  Circles reshaping the RNA world: from waste to treasure.

Authors:  Jing Liu; Tian Liu; Xiaman Wang; Aili He
Journal:  Mol Cancer       Date:  2017-03-09       Impact factor: 27.401

8.  Circ-ZNF609 Is a Circular RNA that Can Be Translated and Functions in Myogenesis.

Authors:  Ivano Legnini; Gaia Di Timoteo; Francesca Rossi; Mariangela Morlando; Francesca Briganti; Olga Sthandier; Alessandro Fatica; Tiziana Santini; Adrian Andronache; Mark Wade; Pietro Laneve; Nikolaus Rajewsky; Irene Bozzoni
Journal:  Mol Cell       Date:  2017-03-23       Impact factor: 17.970

9.  Peripheral blood circular RNA hsa_circ_0124644 can be used as a diagnostic biomarker of coronary artery disease.

Authors:  Zhenzhou Zhao; Xuejie Li; Chuanyu Gao; Dongdong Jian; Peiyuan Hao; Lixin Rao; Muwei Li
Journal:  Sci Rep       Date:  2017-01-03       Impact factor: 4.379

10.  Cell-type specific features of circular RNA expression.

Authors:  Julia Salzman; Raymond E Chen; Mari N Olsen; Peter L Wang; Patrick O Brown
Journal:  PLoS Genet       Date:  2013-09-05       Impact factor: 5.917

View more
  9 in total

1.  Immune Dysfunction Mediated by the ceRNA Regulatory Network in Human Placenta Tissue of Intrahepatic Cholestasis Pregnancy.

Authors:  Yuya Wang; Yan Tang; Xianli Yang; Jie Xu; Yanjie Chen; Jing Xu; Shan Hu; Ping Yi
Journal:  Front Immunol       Date:  2022-06-24       Impact factor: 8.786

2.  Analysis of changes in circular RNA expression and construction of ceRNA networks in human dilated cardiomyopathy.

Authors:  Zhenhao Lin; Yongchao Zhao; Fangjie Dai; Enyong Su; Fuhai Li; Yan Yan
Journal:  J Cell Mol Med       Date:  2021-01-22       Impact factor: 5.310

Review 3.  Circular RNA Expression for Dilated Cardiomyopathy in Hearts and Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Yiyu Zhang; Guoqing Huang; Zhaohu Yuan; Yonggang Zhang; Rong Chang
Journal:  Front Cell Dev Biol       Date:  2021-12-17

4.  Circulating circRNA as biomarkers for dilated cardiomyopathy etiology.

Authors:  Marina C Costa; Maria Calderon-Dominguez; Alipio Mangas; Oscar Campuzano; Georgia Sarquella-Brugada; Mónica Ramos; Maribel Quezada-Feijoo; José Manuel García Pinilla; Ainhoa Robles-Mezcua; Galan Del Aguila Pacheco-Cruz; Thalia Belmonte; Francisco J Enguita; Rocío Toro
Journal:  J Mol Med (Berl)       Date:  2021-09-08       Impact factor: 4.599

5.  Identification of circRNA-miRNA-mRNA Regulatory Network and Autophagy Interaction Network in Atrial Fibrillation Based on Bioinformatics Analysis.

Authors:  Xiaoying Chao; Weiran Dai; Shuo Li; Chenyang Jiang; Zhiyuan Jiang; Guoqiang Zhong
Journal:  Int J Gen Med       Date:  2021-11-19

6.  Comprehensive Analysis of circRNA-miRNA-mRNA Regulatory Network and Novel Potential Biomarkers in Acute Myocardial Infarction.

Authors:  Jiahe Wu; Chenze Li; Zhe Lei; Huanhuan Cai; Yushuang Hu; Yanfang Zhu; Tong Zhang; Haoyan Zhu; Jianlei Cao; Xiaorong Hu
Journal:  Front Cardiovasc Med       Date:  2022-07-07

Review 7.  Circular RNAs: New Players in Cardiomyopathy.

Authors:  Maedeh Bagheri Moghaddam; Majid Maleki; Maziar Oveisee; Mahrokh Bagheri Moghaddam; Maedeh Arabian; Mahshid Malakootian
Journal:  Genes (Basel)       Date:  2022-08-26       Impact factor: 4.141

8.  Bioinformatics analysis of the circRNA-miRNA-mRNA network for atrial fibrillation.

Authors:  Xing Liu; Yiqian Zeng; Zhao Liu; Wenbin Li; Lei Wang; Mingxing Wu
Journal:  Medicine (Baltimore)       Date:  2022-08-26       Impact factor: 1.817

9.  Construction of Immune-Related ceRNA Network in Dilated Cardiomyopathy: Based on Sex Differences.

Authors:  Chang Liu; Jian Liu; Daihong Wu; Shaoling Luo; Weijie Li; Lushan Chen; Zhen Liu; Bingbo Yu
Journal:  Front Genet       Date:  2022-06-08       Impact factor: 4.772

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.